Home Newsfeeds Janney Montgomery Scott Upgrades EPR Props to Buy

Janney Montgomery Scott Upgrades EPR Props to Buy

Janney Montgomery Scott analyst Robert Stevenson upgrades EPR Props (NYSE:EPR) from Neutral to Buy.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Janney Montgomery Scott analyst Robert Stevenson upgrades EPR Props (NYSE:EPR) from Neutral to Buy.

Dow Starts Commercial Operations Of Its Adhesive And Gap Filler Production Line At Its Polyurethanes Systems House In Ahlen, Germany

By Benzinga Newsdesk

May 16, 7:25 AM

Dow (NYSE:DOW) announced today the mechanical completion of its new VORATRON™ Polyurethanes Systems adhesive and gap filler production line at its Polyurethanes Systems House in Ahlen, Germany. Dow

DOW

P/E Ratio Insights for Chipotle Mexican Grill

By Benzinga Insights

September 12, 12:45 PM

In the current market session, Chipotle Mexican Grill Inc. (NYSE:CMG) stock price is at $1921.95, after a 1.38%…

CMG

News

‘Boeing Begins Construction On New Phantom Works Facility’

By Happy Mohamed

May 26, 10:02 AM

https://boeing.mediaroom.com/news-releases-statements?item=131264 - The Advanced Coatings Center is the latest factory supporting innovation efforts - State-of-the-art facility will house critical post-assembly phases

Personalis Joins Top UK Cancer Research Organizations To Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study

By Happy Mohamed

April 5, 8:47 AM

Personalis' NeXT Personal® liquid biopsy assay will be deployed in a collaboration for TRACERx to assess approaches for earlier lung cancer recurrence post-surgery and for relapse Personalis, Inc. (NASDAQ:PSNL),

PSNL

Janney Montgomery Scott Upgrades EPR Props to Buy

Related Posts

Dow Starts Commercial Operations Of Its Adhesive And Gap Filler Production Line At Its Polyurethanes Systems House In Ahlen, Germany

P/E Ratio Insights for Chipotle Mexican Grill

‘Boeing Begins Construction On New Phantom Works Facility’

Personalis Joins Top UK Cancer Research Organizations To Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study